AI-Ready Bio-Data Standards Act
- Sponsor
- Sen. Young, Todd [R-IN]
- Committees
- Commerce, Science, and Transportation Committee (primary)
- Last action
- Mar 12, 2026
Bottom line
The bill aims to standardize federally funded biological data to enhance its utility for artificial intelligence development and accelerate advancements in biotechnology.
What it actually does
This bill directs the National Institute of Standards and Technology (NIST) to establish definitions, standards, resources, and frameworks to ensure biological datasets generated from qualified federally funded research are 'artificial intelligence-ready.' It mandates NIST to develop agency-specific data management policies, create a public database for these datasets, and form an advisory group. The bill also requires annual updates to these standards and regular reports to Congress.
Proponents argue
Supporters argue that this legislation is crucial for accelerating biotechnology and AI innovation by ensuring high-quality, standardized biological data is readily available for training AI models, thereby overcoming current data fragmentation and incompatibility issues and streamlining research and development in critical scientific fields.
Opponents contend
Opponents might express concerns about the potential for increased administrative burden and costs on federally funded researchers, particularly smaller entities, and the risk of stifling scientific flexibility through overly rigid standardization. They might also question the practicality of defining 'AI-ready' across diverse biological datasets.
The bill is relatively short and clearly structured, making it accessible for an informed reader to understand its core directives within a reasonable timeframe.
Section 2(a)
NIST Mandate for AI-Ready Bio-Data Standards
This provision directs the National Institute of Standards and Technology (NIST) to establish definitions for terms like 'artificial intelligence-ready,' 'biomanufacturing,' 'biotechnology,' and 'qualified federally funded research.' It also requires NIST to develop standards for making biological datasets AI-ready, along with data management resources and cybersecurity frameworks for federal agencies and researchers. These must be established within two years and updated annually.
Supporters argue
Supporters argue this is foundational for national competitiveness in AI and biotech, ensuring that valuable research data is interoperable and optimized for advanced analytical tools, thereby accelerating scientific discovery and innovation.
Critics contend
Critics might argue that defining 'AI-ready' broadly could be premature given the evolving nature of AI and biological data, potentially leading to rigid standards that hinder diverse research methodologies or impose unnecessary burdens on researchers.
Tradeoffs
Balances the need for standardization to enable AI applications with the risk of imposing overly prescriptive requirements that could stifle scientific flexibility or create administrative overhead.
Section 2(a)(2)(A)(ii)
Requirements for AI-Ready Data Definition
This sub-provision specifies that the definition of 'artificial intelligence-ready' must ensure a biological dataset is generated and formatted to enable effective use for training AI models and support advancements in AI and biotechnology research. It also grants the Director of NIST discretion, in consultation with a Federal agency's Chief Data Officer, to determine if a dataset is not AI-ready even if it otherwise meets the definition.
Section 2(a)(2)(A)(iii)
Conditions for Qualified Federally Funded Research
This sub-provision mandates that the definition of 'qualified federally funded research' must include specific conditions. These conditions include the amount of federal funding, the recipient's capability and expertise to generate AI-ready biological datasets (including negative data), and the size of the dataset. NIST can add other appropriate conditions.
Section 2(d)
Federal Agency Data Management Policies for AI-Ready Data
This section directs NIST to establish or revise agency-specific data management policies for each federal agency that funds qualified federally funded research. These policies must ensure that biological datasets generated by recipients are AI-ready. Key elements include mechanisms for sufficient federal funding to meet AI-ready requirements and a process for Chief Data Officers to designate compliance individuals. It also mandates oversight mechanisms like a central repository of policies, a public database for AI-ready datasets, and agency reporting/assistance mechanisms.
Section 2(f)
Establishment of AI-Ready Bio-Data Advisory Group
This section mandates the establishment of an advisory group within 180 days to provide recommendations on definitions, standards, resources, and frameworks, review agency policies, and offer guidance to academic journals on AI-ready datasets. The group will comprise representatives from federal agencies, academia, private sector entities, and academic publishers, serving two-year terms.
Section 2(g)
FAR Revisions for AI-Ready Bio-Data Standards
This provision directs the Federal Acquisition Regulatory Council to revise the Federal Acquisition Regulation (FAR) as necessary to implement the definitions, standards, resources, and frameworks established by NIST under the Act.
Requires NIST to ensure that the definitions, standards, resources, and frameworks are 'not overly burdensome' on recipients of funding for qualified federally funded research, specifically stating that generating AI-ready biological datasets should not require resources and expertise beyond those available to the recipients.
Section 2(a)(2)(D)(i)
Why it matters:This is standard legislative practice to include guardrails within the scope of a primary directive. It's not necessarily evasive but could be overlooked by a casual reader.
Case for: Supporters would argue this clause is vital to prevent the new standards from becoming an unfunded mandate or disproportionately impacting smaller research institutions or less-resourced researchers, ensuring equitable participation in federally funded research.
Case against: Critics might argue that 'not overly burdensome' is subjective and could be interpreted loosely, potentially allowing NIST to impose significant new requirements that still strain recipient resources, or that it could lead to less rigorous standards if NIST prioritizes burden reduction over optimal AI-readiness.
Estimated impact: This clause could significantly influence the practical implementation and stringency of the AI-ready data standards, affecting the operational costs and capabilities required of potentially thousands of research entities.
Defines 'negative data' as data that disproves, fails to support, or explains through previously unknown or contradictory means a research hypothesis but that otherwise still advances scientific knowledge or understanding. This is relevant because Section 2(a)(2)(A)(iii)(II) includes the capability to generate negative data as a condition for 'qualified federally funded research.'
Section 2(k)(4)
Why it matters:Standard legislative practice to put definitions at the end. Its importance is in how it shapes the scope of 'qualified federally funded research.'
Case for: Proponents argue that explicitly including negative data is crucial for scientific integrity and accelerating discovery, as knowing what doesn't work is often as valuable as knowing what does, and ensures AI models are trained on a more complete and unbiased dataset.
Case against: No specific opposition is typically raised against defining 'negative data,' but some might argue that mandating its generation or inclusion could add complexity to data collection and curation processes, especially if the definition is difficult to apply consistently across diverse research fields.
Estimated impact: This definition could significantly broaden the scope of data considered valuable for AI training, potentially leading to richer, more robust AI models in biotechnology and a more complete scientific record.